Pharmaceutical manufacturers and contract development and manufacturing organizations increasingly...

A lyophilizer is supposed to freeze and sublimate samples,...

7 Overlooked Generative AI Database Platforms That Top Lab...

There is no doubt in the fact that when...

  Concussions remain one of the most prevalent and undertreated...

FABRX has started a fully automated approach to pharmacy...

Bluesight, a provider of hospital intelligence solutions, has formally...

Bluesight has introduced a fully redesigned 340BCheck platform, describing...

LogiPharma 2026 has concluded on a high, bringing together...

While oral delivery is often preferred, the need for rapid action and precise dosing makes parenteral administration an indispensable tool in modern medicine. New developments in injectable technologies are minimizing patient discomfort while maximizing the efficacy of complex biologics and emergency treatments in clinical settings.

The one-size-fits-all approach to medicine is being replaced by a more nuanced understanding of individual biology. By tailoring the timing, dosage, and delivery method of a drug to a patient's unique genetic profile and lifestyle, precision therapeutics are achieving higher success rates and fundamentally changing the patient experience.

The oral route remains the most preferred method of medication administration due to its non-invasive nature and ease of use. Recent breakthroughs in formulation science are overcoming historical barriers like poor solubility and harsh gastric environments, ensuring that even complex molecules can be delivered effectively through a simple tablet or capsule.

The effectiveness of a medication is often limited not by its potency, but by the frequency and consistency of its administration. Modern developments in timed-release technology are optimizing how drugs are metabolized, maintaining steady therapeutic levels in the bloodstream and significantly enhancing the success rates of long-term treatments.

Syneos Health announced on 14th May 2026 a series...

FABRX has started a fully automated approach to pharmacy...

Bluesight, a provider of hospital intelligence solutions, has formally...

Bluesight has introduced a fully redesigned 340BCheck platform, describing...

Supporting the future of smart manufacturing through precision inspection,...

LogiPharma 2026 has concluded on a high, bringing together...

The resilience of global pharmaceutical manufacturing is inextricably linked to the visibility and stability of its supply network, making the practice of comprehensive risk mapping essential for identifying vulnerabilities and ensuring the continuous flow of critical medicines.

In the complex and highly regulated pharmaceutical environment, the ability to capture, store, and effectively utilize intellectual capital is critical for maintaining robust quality standards and ensuring continuous inspection readiness.

The paradigm shift toward disposable technologies is redefining the architectural and operational foundations of biopharmaceutical manufacturing, enabling rapid reconfiguration and significantly reducing the capital risks associated with traditional stainless-steel infrastructure.

NVIDIA and Eli Lilly and Company have announced the...

Abalone Bio, which is a therapeutics biotech company that...

Samsung Bioepis has begun its direct commercialization of Byooviz,...

Daiichi Sankyo has recently made an announcement of its...

Jiangsu Hengrui Pharmaceuticals, which is a China-based pharmaceutical company that...

The U.S. Food and Drug Administration approves a weight...